Content deleted Content added
m cleanup (wikitables, html markup, layout, etc.) |
m fixed CS1 errors: dates & General fixes using AWB (9803) |
||
Line 29:
| <center>Intradermal</center>
| Right deltoid region of the arm
| BCG given at earliest possible age protects the possibility of TB meningitis and other TB infections in which infants are prone<ref name='PMID15628980'>{{cite journal|title=Protective effect of neonatal BCG vaccines against tuberculous meningitis|journal=[[Bosnian Journal of Basic Medical Sciences]]|date=February 2004
|-
| [[DPT vaccine|Diphtheria-Pertussis-Tetanus Vaccine]]
Line 66:
| <center>Subcutaneous</center>
| Upper outer portion of the arms, Right deltiod
| At least 85% of measles can be prevented by immunization at this age.<ref name='PMID8034506'>{{cite journal|title=Worldwide measles prevention|journal=Israel Journal of Medical Sciences|date=May 1994
|}
Line 74:
* Vaccine combinations (few exceptions), antibiotics, low-dose steroids (less than 20 mg per day), minor infections with low fever (below 38.5º Celsius), diarrhea, malnutrition, kidney or liver disease, heart or lung disease, non-progressive encephalopathy, well controlled epilepsy or advanced age, are not contraindications to vaccination. Contrary to what the majority of doctors may think, vaccines against hepatitis B and tetanus can be applied in any period of the pregnancy.<ref>{{cite web|url=http://saudepublica.web.pt/04-PrevencaoDoenca/Travel/TravelVaccines.htm |title=Management of the Traveler: Vaccination |accessdate=2007-05-12 |year=1997 |work=Travel Medicine |publisher=Portal de Saúde Pública }}</ref>
* There are very few true contraindication and precaution conditions. Only two of these conditions are generally considered to be permanent: severe (anaphylactic) allergic reaction to a vaccine component or following a prior dose of a vaccine, and encephalopathy not due to another identifiable cause occurring within 7 days of pertussis vaccination.<ref>{{cite web|url=http://www.cdc.gov/nip/publications/pink/genrec.pdf |title=General Recommendations on Immunizations |accessdate=2007-05-12 |date=2007-02-14 |format=PDF |work=Epidemiology & Prevention of Vaccine-Preventable Diseases--The Pink Book 10th Edition |publisher=Centers for Disease Control and Prevention }}</ref>
* Only the diluent supplied by the manufacturer should be used to reconstitute a freeze-dried vaccine. A sterile needle and sterile syringe must be used for each vial for adding the diluent to the powder in a single vial or ampoule of freeze-dried vaccine.<ref>{{cite news | first= | last=Department of Vaccines and Biologicals | title=WHO Recommendations for Diluents | date=December 2000
* The only way to be completely safe from exposure to blood-borne diseases from injections, particularly hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) is to use one sterile needle, one sterile syringe for each child.<ref>{{cite news | first=Edward | last=Hoekstra | title=Immunization: Injection Safety | date= | publisher=UNICEF | url =http://www.unicef.org/immunization/23244_safety.html | work =UNICEF Expert Opinion | pages = | accessdate = 2007-05-12 | language = }}</ref>
Line 120:
* all infants born to that mother will be protected
|}
In June 2000, the 57 countries that have not yet achieved elimination of neonatal tetanus were ranked and the Philippines was listed together with 22 other countries in Class A, a classification for countries close to maternal and neonatal tetanus elimination.<ref>{{cite news | first= | last= | title=Maternal and Neonatal Tetanus | date=November 2000
==Care for the Vaccines==
To ensure the optimal potency of vaccines,a careful attention is needed in handling practices at the country level. These include storage and transport of vaccines from the primary vaccine store down to the end-user at the health facility, and further down at the outreach sites.<ref name='WHO/IVB/06.10'>{{cite news | first= | last= | title=Temperature Sensitivity of Vaccines | date=August 2006
A "first expiry and first out" (FEFO) vaccine system is practiced to assure that all vaccines are utilized before its expiry date. Proper arrangement of vaccines and/or labeling of expiry dates are done to identify those close to expiring. Vaccine temperature is monitored twice a day (early in the morning and in the afternoon) in all health facilities and plotted to monitor break in the cold chain. Each level of health facilities has cold chain equipment for use in the storage vaccines which included cold room, freezer, refrigerator, transport box, vaccine carriers, thermometers, cold chain monitors, ice packs, temperature monitoring chart and safety collector boxes.<ref>{{cite book | title = Expanded Program on Immunization Manual | publisher = Department of Health, Philippines | year = 1995 | ___location = Manila, Philippines }}</ref>
| |||